Skip to main content
|

Add a bookmark to get started

Bookmarks info
Andrew Gilbert

Andrew P. Gilbert

Partner

US Chair, Corporate practice

Global Co-Chair, Life Sciences sector

An outstanding lawyer in all respects
— client quoted in Chambers USA
New YorkShort Hills
About

Andrew Gilbert focuses his practice on corporate finance transactions, mergers and acquisitions and securities law matters. He represents public and private companies primarily in the technology, life sciences and healthcare industries, as well as investment firms that serve these sectors.

Andrew brings clients his extensive background representing issuers, underwriters, and venture capital firms in both public and private offerings. He is highly experienced in securities law compliance and corporate governance matters, with transactional experience in IPOs, PIPEs, registered direct offerings and direct follow-on offerings; as well as in venture capital, private equity, mergers and acquisitions, and other strategic transactions. He also has counseled numerous entrepreneurs and emerging growth companies in planning profitable liquidity strategies. Andrew regularly serves as outside general counsel for private and public companies at various stages of development. 

Andrew is a member of the firm's National Leadership group of the US Emerging Growth and Venture Capital practice.

Areas of FocusCorporateMergers and AcquisitionsPrivate EquityEmerging Growth and Venture CapitalEquity Capital MarketsEnergy and Natural ResourcesLife SciencesTechnologyLife Sciences Transactions
Bar admissionsNew YorkNew JerseyPennsylvania
Education
  • J.D., Rutgers University School of Law 1993
    Research Editor, Rutgers Computer and Technology Law Journal
  • B.A., Colgate University 1988

Awards

  • Chambers USA
    • Band 1, New Jersey Corporate/M&A (2021-2023)
      Chambers comments, "Andrew Gilbert represents companies from a range of industries in business sales, acquisitions and other corporate and financing matters."  Clients say, "He is very knowledgeable and can provide insight into the main issues of a deal and how to get them resolved." "He is practical and oriented toward getting transactions done." "An outstanding lawyer in all respects - I am continually amazed at his expertise." "Andrew is an incredibly capable securities and governance guru."
  • The Legal 500 United States
    • Recommended, Healthcare: Life Sciences (2020-2022)
      The Legal 500 comments, "Fellow co-head Andrew Gilbert, on the transactional side, with deep experience in M&A, public and private offerings, and investment deals."
    • Recommended, Venture Capital & Emerging Companies (2018-2019)
  • Roi-nj.com – Technology Influencer (April 2022)
  • Recognized in The Best Lawyers in America and as a New Jersey Super Lawyer in every year since 2008
  • Named to NJBIZ's Top 40 under 40 list (2003)
  • The M&A Atlas Awards, Pharma & Devices Deal of the Year, Winner 2016: Tribute Pharmaceuticals Canada merger with POZEN (Aralez Pharmaceuticals)
  • The M&A Atlas Awards, Outstanding M&A Law Firm of the Year Finalist 2016: DLA Piper
  • Winner of the New Jersey Technology Council's 2016 Legend of Technology Award
  • Financial Services Deal of the Year Award (over US $100 million) from M&A Advisor in the representation of LLR Partners in the acquisition of CompoSecure, LLC, a leading designer and manufacturer of proprietary financial cards (2015)

For more information, pursuant to New Jersey Lawyer Advertising guidance, please click here.

Bylines

Seminars

Prior Experience

Prior to joining DLA Piper, Andrew was a partner at an international law firm. Before attending law school, he served as an intern with the NASDAQ trading and corporate bond departments at Shearson Lehman Brothers Inc. and worked as an underwriter for American International Group (AIG). At AIG, Andrew underwrote professional liability and directors' and officers' legal liability insurance policies for several financial services companies.

Memberships And Affiliations

  • Director, New Jersey Technology Council

My latest insights

Past event
image

Understanding trends in life sciences: Navigating 2023 challenges

11 May 2023 .2 minute read

News
image

DLA Piper advises Overhaul in its acquisition of SensiGuard® and securing of US$73 million...

17 March 2023 .2 minute read

News
image

DLA Piper Represents Liquidia Corporation in US$100 Million Revenue Interest Financing...

30 January 2023 .2 minute read

View All

Connect

Phone

+1 973 520 2553
(Work, New Jersey - Short Hills)
+1 908 400 2105
(Mobile)
CallvCardLinkedInPrint
Privacy policyLegal noticesCookie policyModern slaveryWhistleblowingSitemap

DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.

© 2023 DLA Piper